Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Birth Control Clinical Trials

A listing of Birth Control medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (10) clinical trials

Women's Health Research Ctr. is conducting a clinical research study of an investigational oral medication for birth control. Patient Inclusion Criteria: Females ages 18-40 years of age, sexually active, and have regular menstrual cycles are eligible for participation in a 12 month study for birth control. Patient Exclusion Criteria: Must ...

Phase

Are you interested in a research study of a new investigational birth control patch? If you are: Sexually active and willing to try a different method of birth control; or Interested in being in a study for an investigational method of birth control that is non-invasive …then you may be ...

Phase

Healthy women, who are sexually active, at risk of pregnancy, and desiring contraception.

Phase

Birth Control Study

Phase

Northern California Research is currently enrolling participants for a birth control study. The purpose of this study is to assess the effectiveness of a new form of birth control in preventing pregnancy. The study medication is a new, non-hormonal, birth control designed to maintain the pH of the vagina and ...

Phase

A SINGLE-ARM, PHASE III, OPEN-LABEL, MULTICENTER, STUDY IN WOMEN AGED 18-35 YEARS OF THE CONTRACEPTIVE EFFICACY AND SAFETY OF AMPHORA® CONTRACEPTIVE VAGINAL GEL (AMPOWER)

Phase

Continuous Versus Cyclic Use of Oral Contraceptive Pills in Adolescents

Oral contraceptive pills have traditionally been prescribed in a cyclical manner, where there are 21-24 days of active pills and 4-7 days of placebo pills or a pill-free interval, creating a 28-day cycle. It has now been proven that as long as a woman has both estrogen and progesterone, her ...

Phase

AMP002 Phase III Contraceptive Study

Through assessments including pelvic examination, laboratory procedures, and medical and gynecological history, subjects will be screened for eligibility in order to enroll approximately 1350 subjects into the study. After a screening period of up to 60 days, enrolled women will receive study drug. Each woman will participate in the study ...

Phase